GlassScriptPhysician profile
James J Kelly
NPI 1730260480
$16,518.60
in general payments reported to CMS, 2019-2025
64 companies · $1,923 in 2025
The $1,923 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,027 · 2020: $2,087 · 2021: $3,122 · 2022: $2,725 · 2023: $2,105 · 2024: $2,529 · 2025: $1,923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,525 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,525.36 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,666.60 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,017.43 | 2019-2025 | |
| Pfizer INC. | $993.38 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $889.82 | 2019-2025 | Xifaxan, Trulance |
| Amgen INC. | $822.42 | 2019-2025 | Repatha, Otezla, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $821.90 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Astrazeneca Pharmaceuticals LP | $753.31 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Janssen Pharmaceuticals, INC | $722.36 | 2019-2024 | Xarelto |
| Glaxosmithkline, LLC. | $715.32 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $692.99 | 2019-2025 | Verquvo, Belsomra, Steglatro |
| Lilly USA, LLC | $594.93 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Forte Bio-Pharma LLC | $580.86 | 2020-2025 | Prolate, Nalocet, Tanlor |
| Abbott Laboratories | $523.11 | 2021-2025 | Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $496.60 | 2022-2025 | |
| Sunovion Pharmaceuticals INC. | $449.22 | 2019-2022 |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $449.03 | 2019-2022 | |
| Ironwood Pharmaceuticals, INC | $446.79 | 2019-2025 | Linzess |
| Astellas Pharma US INC | $316.82 | 2019-2024 | Veozah, Myrbetriq |
| Allergan, INC. | $269.72 | 2019-2020 | |
| Novo Nordisk INC | $257.20 | 2019-2025 | Ozempic, Rybelsus, Saxenda |
| Takeda Pharmaceuticals U.S.A., INC. | $238.52 | 2019-2022 | |
| Corcept Therapeutics | $222.08 | 2021-2025 | Korlym |
| Sanofi-Aventis U.S. LLC | $218.42 | 2019-2022 | |
| Irhythm Technologies, INC. | $190.50 | 2024 | Zio Xt Patch, Zio Monitor |
| Dexcom, INC. | $189.24 | 2024-2025 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $164.06 | 2023-2025 | Gemtesa |
| Esperion Therapeutics, INC. | $152.14 | 2020-2025 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $134.42 | 2019-2024 | Camzyos |
| Exact Sciences Corporation | $114.61 | 2023-2025 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $107.51 | 2021-2025 | Injectafer |
| Vifor Pharma, INC. | $104.61 | 2020-2021 | |
| Mylan Specialty L.P. | $97.02 | 2019-2023 | Yupelri |
| Eisai INC. | $88.29 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $83.65 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $68.70 | 2023-2025 | Rexulti |
| Horizon Therapeutics Plc | $58.82 | 2019-2020 | |
| Axsome Therapeutics, INC. | $54.77 | 2025 | Auvelity |
| Nestle Healthcare Nutrition INC. | $51.79 | 2021-2022 | |
| Shield Therapeutics INC | $51.05 | 2024-2025 | |
| Boston Scientific Corporation | $49.33 | 2019-2023 | Watchman Flx |
| Scilex Pharmaceuticals INC. | $48.88 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $46.83 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $38.25 | 2025 | Caplyta |
| Theratechnologies INC. | $37.62 | 2019 | |
| Almatica Pharma LLC | $32.56 | 2021 | |
| Gilead Sciences, INC. | $29.65 | 2019-2024 | |
| Phathom Pharmaceuticals, INC. | $28.24 | 2025 | Voquezna |
| Genentech USA, INC. | $28.14 | 2020-2021 | |
| Upsher-Smith Laboratories LLC | $28.07 | 2020 | |
| Avion Pharmaceuticals | $26.53 | 2020 | |
| Edwards Lifesciences Corporation | $26.19 | 2022-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Seqirus USA INC | $24.05 | 2025 | Flucelvax, Fluad |
| Advanced Respiratory, INC | $23.47 | 2021 | |
| Kyowa Kirin, INC. | $22.55 | 2024 | Crysvita |
| Ardelyx, INC. | $21.59 | 2024 | Ibsrela |
| Sanofi Pasteur INC. | $20.59 | 2023 | |
| Acrotech Biopharma INC. | $19.07 | 2025 | Beleodaq |
| Lexicon Pharmaceuticals, INC. | $18.08 | 2023 | Inpefa |
| Medicure Pharma INC. | $16.84 | 2021 | |
| Alnylam Pharmaceuticals INC. | $14.30 | 2022 | |
| The Binding Site INC. | $14.23 | 2024 | Freelite |
| Ultragenyx Pharmaceutical INC. | $11.89 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.42 | 2020 | |
| Cvrx, INC. | $10.22 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.